Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Simonetta Bulletti
Observed names:
S Bulletti,
S. Bulletti
Institution:
University of Perugia
Observed institutions:
University of Perugia,
Azienda Ospedaliera di Perugia,
Azienda Sanitaria Unità Locale di Reggio Emilia,
Regione Umbria,
Azienda Unità Sanitaria Locale Umbria n. 2
OpenAlex ID:
A5108704350
p16/ki67 and E6/E7 mRNA Accuracy and Prognostic Value in Triaging HPV DNA-Positive Women
2020
·
Paolo Giorgi Rossi
, Francesca Carozzi
, et al.
·
JNCI Journal of the National Cancer Institute
·
102
PDF
Use of Cytology, E6/E7 mRNA, and p16 INK4a –Ki-67 to Define the Management of Human Papillomavirus (HPV)–Positive Women in Cervical Cancer Screening
2015
·
Daniela Gustinucci
, Paolo Giorgi Rossi
, et al.
·
American Journal of Clinical Pathology
·
74
Performance of HPV E6 / E7 mRNA assay as primary screening test: Results from the NTCC2 trial
2022
·
Paolo Giorgi Rossi
, Guglielmo Ronco
, et al.
·
International Journal of Cancer
·
48
Role of p16INK4a Cytology Testing as an Adjunct to Enhance the Diagnostic Specificity and Accuracy in Human Papillomavirus-Positive Women within an Organized Cervical Cancer Screening Program
2012
·
Daniela Gustinucci
, Basilio Passamonti
, et al.
·
Acta Cytologica
·
40
Cancer patients as `experts' in defining quality of life domains. A multicentre survey by the Italian Group for the Evaluation of Outcomes in Oncology (IGEO)
2000
·
M. Costantini
, E. Mencaglia
, et al.
·
Quality of Life Research
·
40
A comparative effectiveness trial of two faecal immunochemical tests for haemoglobin (FIT). Assessment of test performance and adherence in a single round of a population-based screening programme for colorectal cancer
2016
·
Basilio Passamonti
, Morena Malaspina
, et al.
·
Gut
·
38
Interobserver reproducibility of cytologic p16INK4a/Ki‐67 dual immunostaining in human papillomavirus‐positive women
2016
·
Maria Benevolo
, Elena Allia
, et al.
·
Cancer Cytopathology
·
35
PDF
Cervical human papilloma virus (HPV) DNA primary screening test: Results of a population-based screening programme in central Italy
2016
·
Basilio Passamonti
, Daniela Gustinucci
, et al.
·
Journal of Medical Screening
·
28
Evaluation of the FocalPoint GS System Performance in an Italian Population-Based Screening of Cervical Abnormalities
2007
·
Basilio Passamonti
, Simonetta Bulletti
, et al.
·
Acta Cytologica
·
19
Accuracy of different triage strategies for human papillomavirus positivity in an Italian screening population
2021
·
Daniela Gustinucci
, Maria Benevolo
, et al.
·
International Journal of Cancer
·
17
PDF
Interlaboratory concordance of p16/Ki‐67 dual‐staining interpretation in HPV‐positive women in a screening population
2020
·
Maria Benevolo
, Pamela Mancuso
, et al.
·
Cancer Cytopathology
·
17
PDF
Clinical relevance of partial HPV16/18 genotyping in stratifying HPV‐positive women attending routine cervical cancer screening: a population‐based cohort study
2021
·
S Gori
, J Battagello
, et al.
·
BJOG An International Journal of Obstetrics & Gynaecology
·
16
Determinants of Viral Oncogene E6-E7 mRNA Overexpression in a Population-Based Large Sample of Women Infected by High-Risk Human Papillomavirus Types
2017
·
Paolo Giorgi Rossi
, Simonetta Bisanzi
, et al.
·
Journal of Clinical Microbiology
·
16
Italian guidelines for cervical cancer screening. Multisocietal recommendations on the use of biomarkers in HPV screening with risk-based approach and GRADE methodology
2025
·
Silvia Gori
, Francesco Venturelli
, et al.
·
British Journal of Cancer
·
15
Expression of p16 in abnormal pap-tests as an indicator of CIN2+ lesions: a possible role in the low grade ASC/US and L/SIL (Ig) cytologic lesions for screening prevention of uterine cervical tumours.
2010
·
B Passamonti
, D Gustinucci
, et al.
·
PubMed
·
13
Extended HPV genotyping by the BD Onclarity assay: concordance with screening HPV-DNA assays, triage biomarkers, and histopathology in women from the NTCC2 study
2024
·
Laura De Marco
, Simonetta Bisanzi
, et al.
·
Microbiology Spectrum
·
12
Determinants of p16/Ki‐67 adequacy and positivity in HPV‐positive women from a screening population
2020
·
Maria Benevolo
, Pamela Mancuso
, et al.
·
Cancer Cytopathology
·
12
PDF
Impact of differentiating between persistent and new infections on colposcopy referral in HPV-positive triage-negative women: results from the NTCC2 study
2025
·
Annarosa Del Mistro
, Pamela Mancuso
, et al.
·
Infectious Agents and Cancer
·
3
PDF
[Evaluation of quality of life in oncology. Rationale and objectives of the first phase of the Quality of Life in Oncology project].
1997
·
M Costantini
, E Mencaglia
, et al.
·
PubMed
·
2
Correction: Italian guidelines for cervical cancer screening. Multisocietal recommendations on the use of biomarkers in HPV screening with risk-based approach and GRADE methodology
2025
·
Silvia Gori
, Francesco Venturelli
, et al.
·
British Journal of Cancer
·
1
PDF
Cervical Human Papilloma Virus (HPV) DNA Primary Screening Test Results of the Experience of a Regional Laboratory in Central Italy
2014
·
B.U. Passamonti
, S. Bulletti
, et al.
·
Value in Health
·
1
PDF
Long-term CIN3+ risk stratification of HPV-positive women by cytology, p16/ki67 dual staining, and extended genotyping: 7·5-year follow-up of the NTCC2 randomised clinical trial
2026
·
Paolo Giorgi Rossi
, Pamela Mancuso
, et al.
·
SSRN Electronic Journal
PDF
Front & Back Matter
2012
·
Federico Álvarez-Rodriguez
, Margarita Gimeno-Aranguez
, et al.
·
Acta Cytologica
Contributor Index Vol. 51, 2007
2007
·
Ian Michael Storch
, Daniel Andrew Sussman
, et al.
·
Acta Cytologica
PDF
Objective and rational evaluation of the quality of life in oncology in the first phase of the QVONC project
1997
·
Massimo Costantini
, Emanuela Mencaglia
, et al.
Show more works
View as search
Works count:
25
Citation count:
549
H-index:
14
I10-index:
17
Year
Topic
Type